Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 14;20(10):2370.
doi: 10.3390/ijms20102370.

SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers?

Asher Ornoy  1 , Gideon Koren  2
Affiliations
Review

SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers?

Asher Ornoy et al. Int J Mol Sci. .

Abstract

Serotonin has important roles in the development of the brain and other organs. Manipulations of synaptic serotonin by drugs such as serotonin reuptake inhibitors (SRI) or serotonin norepinephrine reuptake inhibitors (SNRI) might alter their development and function. Of interest, most studies on the outcome of prenatal exposure to SRI in human have not found significant embryonic or fetal damage, except for a possible, slight increase in cardiac malformations. In up to a third of newborns exposed to SRI, exposure may induce transient neonatal behavioral changes (poor neonatal adaptation) and increased rate of persistent pulmonary hypertension. Prenatal SRI may also cause slight motor delay and language impairment but these are transient. The data on the possible association of prenatal SRIs with autism spectrum disorder (ASD) are inconsistent, and seem to be related to pre-pregnancy treatment or to maternal depression. Prenatal SRIs also appear to affect the hypothalamic hypophyseal adrenal (HPA) axis inducing epigenetic changes, but the long-term consequences of these effects on humans are as yet unknown. SRIs are metabolized in the liver by several cytochrome P450 (CYP) enzymes. Faster metabolism of most SRIs in late pregnancy leads to lower maternal concentrations, and thus potentially to decreased efficacy which is more prominent in women that are rapid metabolizers. Studies suggest that the serotonin transporter SLC6A4 promoter is associated with adverse neonatal outcomes after SRI exposure. Since maternal depression may adversely affect the child's development, one has to consider the risk of SRI discontinuation on the fetus and the child. As with any drug treatment in pregnancy, the benefits to the mother should be considered versus the possible hazards to the developing embryo/fetus.

Keywords: ASD; SNRIs; SRI; SSRIs; epigenetic effects; malformations; neurodevelopmental effects; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Berger M., Gray J.A., Roth B.L. The expanded biology of serotonin. Annu. Rev. Med. 2009;60:355–366. doi: 10.1146/annurev.med.60.042307.110802. - DOI - PMC - PubMed
    1. Brummelte S., Mc Glanaghy E., Bonnin A., Oberlander T.F. Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation. Neuroscience. 2017;342:212–231. doi: 10.1016/j.neuroscience.2016.02.037. - DOI - PMC - PubMed
    1. Oberlander T.F. Fetal serotonin signaling: Setting pathways for early childhood development and behavior. J. Adolesc. Health. 2012;51(Suppl. 2):S9–S16. doi: 10.1016/j.jadohealth.2012.04.009. - DOI - PubMed
    1. Monti J.M. Serotonin control of sleep-wake behavior. Sleep Med. Rev. 2011;15:269–281. doi: 10.1016/j.smrv.2010.11.003. - DOI - PubMed
    1. Diav-Citrin O., Ornoy A. Selective serotonin reuptake inhibitors in human pregnancy: To treat or not to treat. Obstet. Gynecol. Int. 2012;2012:1–12. doi: 10.1155/2012/698947. - DOI - PMC - PubMed

MeSH terms

Substances